Surgical sealants, adhesives, and hemostats (SAH) are the products used to close surgical incisions, post-surgical application, block the passage of fluids through the surface or openings of the wounds, and also to avoid microbial adhesions and infections.
New York, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Surgical Sealants, Adhesives and Hemostats Global Market - Forecast to 2029" - https://www.reportlinker.com/p06321093/?utm_source=GNW Sealants and adhesives are usually considered together as they both adhere to and seal the surgical incisions, while, hemostats are used to achieve hemostasis when the conventional method is ineffective and impractical. According to IQ4I analysis, the SAH global market is expected to grow at mid-single digit CAGR from 2022 to 2029 to reach $4,366.0 million by 2029. The SAH global market is mainly segmented based on products, applications, end-users, and based on geography. The product market is segmented into sealant, adhesive and hemostat. Among these, the hemostat accounted for the largest revenue in 2022 and is expected to grow at mid-single digit CAGR from 2022 to 2029. The sealants are further segmented based on their origin into natural and synthetic sealants. The synthetic sealant accounted for the largest revenue in 2022 and is expected to grow at mid-single digit CAGR from 2022 to 2029. The natural sealants are further sub-segmented based on composition into fibrin and albumin sealants. Among them, fibrin accounted for the largest revenue in 2022 and is expected to grow at low-single digit CAGR from 2022 to 2029. The synthetic sealants are further segmented based on composition into cyanoacrylate, hydrogels, and others. Among them, hydrogels accounted for the largest revenue in 2022 and are expected to grow at mid-single digit CAGR from 2022 to 2029. The adhesive market is segmented into natural and synthetic adhesives, among them; synthetic adhesives accounted for the largest revenue in 2022 and are expected to grow at low-single digit CAGR from 2022 to 2029. The natural adhesives are further sub-segmented based on composition into fibrin and albumin, among them, fibrin adhesive accounted for the largest revenue in 2022 and is expected to grow at low-single digit CAGR from 2022 to 2029. The synthetic adhesives are further segmented based on composition into cyanoacrylate and polyurethane. The cyanoacrylate adhesive accounted for the largest revenue in 2022 and is expected to grow at low-single digit CAGR from 2022 to 2029. Hemostats are classified based on function into mechanical hemostats, active hemostats, flowable hemostats, and fibrin sealants hemostats, among them, the mechanical hemostats accounted for the largest revenue in 2022 and are expected to grow at mid-single digit CAGR from 2022 to 2029. Fibrin sealant hemostat is the fastest growing segment at high-single digit strong CAGR from 2022 to 2029 because it is unique, powerful and effective for localized and diffused bleeding during surgical procedures. The application market is segmented into Cardiovascular surgery, General Surgery, Orthopedic surgery, Urology, Pulmonology, Neurosurgery, Gynecology, Cosmetic surgery and Others. The general surgery segment accounted for the largest revenue in 2022 and is expected to grow at low-single digit CAGR from 2022 to 2029, because of high demand for various surgical procedures. Cosmetic surgery is the fastest growing segment at high-single digit CAGR, because of the advancements in treatment regimes available and better cosmetic outcomes. The end-users market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment accounted for the largest share in 2022 and is expected to grow at mid-single digit CAGR from 2022 to 2029, due to an increase in the aging population, increase in surgical procedural volumes, and better patient care services with advanced facilities. Some of the major players in the SAH market include Baxter International Inc. (U.S.), Johnson & Johnson (Ethicon) (U.S.), Becton, Dickinson & Company (C.R.Bard) (U.S.), Integra Lifescience (U.S.), B.Braun Melsungen AG (Germany), Teleflex (U.S.), Medtronic Plc (Ireland), Artivion Inc. (Cryolife) (U.S.), Advanced Medical Solutions Group Plc (U.K.), Tissium (France), Corza Medical, Inc. (U.S.), Healthium (India), Meril Lifesciences (India), Hemostasis (U.S.), Stryker (U.S.), and Terumo (Japan). Read the full report: https://www.reportlinker.com/p06321093/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________
The Federal Reserve's No. 2 official on Friday added her full endorsement of the U.S. central bank's higher-for-longer game plan for interest rates to curb inflation that new data shows is still running at more than three times policymakers' 2% target. In her first public remarks since the Fed's decision last week to raise its benchmark interest rate by three-quarters of a percentage point for a third straight time, Fed Vice Chair Lael Brainard said: "Monetary policy is focused on restoring price stability in a high-inflation environment." "It will take time for the full effect of tighter financial conditions" caused by rate rises to work its way through the economy and lower price pressures, Brainard said in a speech to a New York Fed conference focused on financial stability and monetary policy.
U.S. stocks opened lower Friday, feeling pressure after the Federal Reserve's preferred inflation measure showed prices increased more than expected in August. The core personal-consumption price index, which strips out food and energy costs, rose 0.6% in August, compared with a forecast for a 0.5% increase. Investors were also monitoring a speech by Russian President Vladimir Putin, who announced plans to annex large swaths of Ukrainian territory. The Dow Jones Industrial Average fell 84 points
Social Security benefits can provide you with a stream of retirement income that is reliable. Deciding when to take benefits is an important question, especially if you're married and hope to qualify for spousal benefits. If you're already taking Social … Continue reading → The post Rules for Switching Social Security Benefits appeared first on SmartAsset Blog.
(Reuters) -Intel Corp's self-driving unit Mobileye on Friday unveiled its filing for a U.S. initial public offering, testing support for a high profile stock debut even as the market for new issues has virtually collapsed. The tech IPO market globally is in the middle of its worst drought in nearly two decades. Mobileye's IPO, coming on the heels of Porsche's blockbuster debut in Europe, could, however, be an early sign of improving investor sentiment.
If approved, Sarepta's (SRPT) SRP-9001 will be the first gene therapy for DMD indication in the United States. The company seeks approval for gene therapy under the accelerated pathway.
Thursday, electric-vehicle start-up Lordstown Motors announced it has started to produce the Endurance battery-powered truck.
In the latest trading session, Kinder Morgan (KMI) closed at $16.72, marking a -0.71% move from the previous day.
Buying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a watchlist?
BlackRock’s Rick Rieder oversees more than $2 trillion in global fixed-income assets. His favorite holding: short-term credit from AAA-rated borrowers.
You invest money to grow it but emotions can play a significant role in your decision-making when trying to prevent losing money. Prospect theory is the idea that people value gains and losses differently, even when potential outcomes are the … Continue reading → The post Prospect Theory: Investment Guide appeared first on SmartAsset Blog.
Tencent is resetting its M&A strategy to put more focus on buying majority stakes mainly in overseas gaming companies, as the tech giant eyes global expansion to offset slowing growth at home in China, people with direct knowledge of the matter said. Tencent Holding Ltd has for years invested in hundreds of up-and-coming businesses, mainly in the onshore market. It has typically acquired minority stakes and stayed invested as a passive financial investor.
If approved, BioMarin's (BMRN) valoctocogene roxaparvovec will be the first gene therapy for hemophilia A in the United States. The FDA filing also incorporates BMRN's responses to the CRL issued to the BLA in 2020.
NTB and AXAHY made it to the Zacks Rank #1 (Strong Buy) income stocks list on September 30, 2022.
No one ever accused September of being a strong month for the market, and that's still true. Here's why we closed out Nucor and trimmed AMD, while building up PepsiCo and buying into Lockheed Martin.
Builders FirstSource (BLDR) closed at $58.20 in the latest trading session, marking a -0.44% move from the prior day.
Major indexes fell to session lows at the market close today. The Dow Jones Industrial Average sold off 1.7%, at levels last seen in November 2020. The S&P 500 pared some of the morning's 0.5% loss but lost ground again to close 1.
Alpharetta Housewives LLC is taking over the ATL.
In the latest trading session, New Fortress Energy (NFE) closed at $44.53, marking a -0.24% move from the previous day.
Japan's factories ramped up output for a third straight month in August, as the manufacturing sector showed resilience in the face of high energy and material costs and worries about a global economic slowdown. Prime Minister Fumio Kishida on Friday ordered his cabinet ministers to compile an economic stimulus package that will include measures to alleviate the burden faced by businesses and households from rising prices. Policymakers in the world's third-largest economy are concerned about recession risks in the United States and other major trading partners, which would make Japan increasingly reliant on domestic consumption for growth.
ADP, a leader in the Big Cap 20, builds base a base within a tight job market and a downturn in the stock market.